Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hans DeVries

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
European Journal of Endocrinology|November 4, 2011
Continuous glucose monitoring: coming of age?J Hans DeVries
Diabetes Technology & Therapeutics|October 24, 2009
Comment on Owens and BolliJ Hans DeVries
Journal of Diabetes Science and Technology|November 4, 2009
Combining insulin pumps and continuous glucose monitors; where are we to go from here?J Hans DeVries
The New England Journal of Medicine|October 11, 2013
Threshold insulin-pump interruption to reduce hypoglycemiaJ Hans DeVries
The New England Journal of Medicine|October 6, 2009
Therapies for type 2 diabetes and coronary artery diseaseJ Hans DeVries
The Lancet. Diabetes & Endocrinology|January 18, 2017
The artificial pancreas-ready for prime time?J Hans DeVries
Current Diabetes Reviews|January 29, 2008
Will long acting insulin analogs influence the use of insulin pump therapy in type 1 diabetes?J Hans DeVries
Diabetes Care|December 25, 2012
Comment on: Rizzo et al. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care 2012;35:2076-2082J Hans Devries
Diabetes|April 25, 2013
Glucose variability: where it is important and how to measure itJ Hans DeVries
The Lancet. Diabetes & Endocrinology|March 14, 2014
Intensive insulin therapy for type 2 diabetes at diagnosisJ Hans DeVries
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
European Journal of Endocrinology|November 4, 2011
Continuous glucose monitoring: coming of age?J Hans DeVries
Diabetes Technology & Therapeutics|October 24, 2009
Comment on Owens and BolliJ Hans DeVries
Journal of Diabetes Science and Technology|November 4, 2009
Combining insulin pumps and continuous glucose monitors; where are we to go from here?J Hans DeVries
The New England Journal of Medicine|October 11, 2013
Threshold insulin-pump interruption to reduce hypoglycemiaJ Hans DeVries
The New England Journal of Medicine|October 6, 2009
Therapies for type 2 diabetes and coronary artery diseaseJ Hans DeVries
The Lancet. Diabetes & Endocrinology|January 18, 2017
The artificial pancreas-ready for prime time?J Hans DeVries
Current Diabetes Reviews|January 29, 2008
Will long acting insulin analogs influence the use of insulin pump therapy in type 1 diabetes?J Hans DeVries
Diabetes Care|December 25, 2012
Comment on: Rizzo et al. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care 2012;35:2076-2082J Hans Devries
Diabetes|April 25, 2013
Glucose variability: where it is important and how to measure itJ Hans DeVries
The Lancet. Diabetes & Endocrinology|March 14, 2014
Intensive insulin therapy for type 2 diabetes at diagnosisJ Hans DeVries
Pageof 23